21.59
+0.59(+2.81%)
Currency In USD
| Previous Close | 21 |
| Open | 21.08 |
| Day High | 21.71 |
| Day Low | 20.99 |
| 52-Week High | 35.72 |
| 52-Week Low | 16.1 |
| Volume | 1.82M |
| Average Volume | 2.58M |
| Market Cap | 2.73B |
| PE | 59.97 |
| EPS | 0.36 |
| Moving Average 50 Days | 23.12 |
| Moving Average 200 Days | 22.19 |
| Change | 0.59 |
If you invested $1000 in Apellis Pharmaceuticals, Inc. (APLS) since IPO date, it would be worth $1,538.85 as of November 26, 2025 at a share price of $21.59. Whereas If you bought $1000 worth of Apellis Pharmaceuticals, Inc. (APLS) shares 5 years ago, it would be worth $457.22 as of November 26, 2025 at a share price of $21.59.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Apellis Announces 5-Year GALE Data Showing SYFOVRE® (pegcetacoplan injection) Delayed Progression of Geographic Atrophy by ~1.5 Years
GlobeNewswire Inc.
Nov 12, 2025 12:00 PM GMT
WALTHAM, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study following five years of continuous treatment with SYFOVRE® (pegcetacoplan injec
Apellis Pharmaceuticals to Present at the Stifel 2025 Healthcare Conference
GlobeNewswire Inc.
Nov 05, 2025 12:00 PM GMT
WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the Stifel 2025 Healthcare Conference on Wednesday, November 12, 2025 at 2:40 p.m. ET. The live conferen
New One-Year Data Reinforcing the Robust and Sustained Efficacy of EMPAVELI® (pegcetacoplan) in C3G and Primary IC-MPGN to be Presented at ASN Kidney Week
GlobeNewswire Inc.
Oct 20, 2025 11:00 AM GMT
Significant proteinuria reduction maintained at one year, regardless of immunosuppressant use or baseline proteinuria levels Complete proteinuria remission (UPCR ≤0.5 g/g) achieved in one-third of patients and sustained through one yearTwo indirect t